Since its establishment more than 20 years ago, the company has pioneered single and double series reagents for enzymatic diagnosis in China, and successfully developed more than 80 varieties, more than 200 specifications and double biochemical reagents for liver function, blood lipid, renal function, myocardium, special proteins, trace elements and glucose metabolism. Diagnostic reagent series products were rated as top products in Beijing New Technology Industry Development Experimental Zone from1990 to 2000 by Beijing Bureau of Quality and Technical Supervision and Beijing Economic Commission, as famous brand products in Beijing by People's Daily and other authoritative organizations in 2002, and as the first brand in China diagnostic reagent market in 2005. While maintaining the rapid growth of sales of biochemical diagnosis series products, the product structure has been continuously expanded, covering all branches of IVD industry. Immunodiagnosis series products and molecular diagnosis series products have been successfully developed, and the manufacturing system has been improved day by day.
In 2002, the company passed the ISO900 1 quality system certification, and in July 2004, it successfully passed the ISO 13485 medical device quality management system certification, with the strictest and complete quality system. In 2005, the company built a new base covering an area of 1 1000 square meters in strict accordance with GMP standards, equipped with domestic first-class automatic production equipment, and adopted international advanced management mode to realize advanced production technologies such as microcomputer networking and automatic online. After more than 20 years of rapid development, Zhongsheng Beijing Control Company has more than 500 agents and sellers, and has more than 75% users in this industry, forming a nationwide sales network and becoming the largest market share enterprise in the domestic IVD industry. At the same time, the company's series of products have passed the EU CE certification, and the overseas market has been expanding.
Since its establishment, Zhongsheng Beijing Control Company has been taking promoting the development of IVD industry as its own responsibility, following the enterprise spirit of "honesty, cooperation, dedication and innovation", pursuing the overall diversified development goal, constantly enriching the product structure, expanding the industrial chain and improving the product quality. Zhongsheng Beijing Control Company has developed into a group company with several subsidiaries. Its products mainly include in vitro diagnostic products and protein drugs, including protein polypeptide drugs (lumbrokinase, etc. ), biochemical diagnostic reagents, immunodiagnostic reagents, molecular diagnostic products, biochemical analyzers, immunodetection analyzers, maternal and child health rapid diagnostic products, gold standard rapid diagnostic products, reference products and quality control products.
Facing the future, Zhongsheng Beijing Control will seize new opportunities and meet new challenges, strive to build a clinical biochemical detection system and immune detection system with independent intellectual property rights and international cost-effective advantages in China, continuously introduce and absorb advanced technologies, digest and absorb them according to their own advantages and characteristics, persist in taking independent innovation as an inexhaustible motive force for the company's survival and development, and aim at becoming an internationally competitive industrial pioneer in protein, making contributions to China's biomedical industry and serving human health.